Collegeville, PA, United States of America

Daniel J Mercer

This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Smithkline Beecham Corporation. Active years: 2004-2006.


% Patents Active = 50.0


Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 14(Granted Patents)


Location History:

  • King of Prussia, PA (US) (2004)
  • Collegeville, PA (US) (2006)

Company Filing History:


Years Active: 2004-2006

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Daniel J Mercer

Introduction

Daniel J Mercer is a notable inventor based in Collegeville, PA (US). He has made significant contributions to the field of biochemistry, particularly through his innovative patents. With a total of 2 patents, Mercer has focused on developing novel compounds that have potential applications in medical treatments.

Latest Patents

Mercer's latest patents include advancements in peptide deformylase inhibitors and fatty acid synthase inhibitors. The first patent provides novel PDF inhibitors and outlines methods for their use. The second patent relates to the use of compounds as inhibitors of the fatty acid synthase FabH, showcasing his commitment to addressing critical biochemical challenges.

Career Highlights

Throughout his career, Mercer has worked with prominent companies such as SmithKline Beecham Corporation and GlaxoSmithKline LLC. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the pharmaceutical industry.

Collaborations

Mercer has collaborated with esteemed colleagues, including Jia-Ning Xiang and Siegfried B Christensen. These partnerships have further enhanced his research and development efforts, leading to innovative solutions in his field.

Conclusion

Daniel J Mercer exemplifies the spirit of innovation in biochemistry through his patents and collaborations. His work continues to influence the development of new therapeutic compounds, making a lasting impact in the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…